Skip to content
The Mumbai

Morepen Labs Submits First US ANDA For Sitagliptin Tablets In 3 Strengths

Morepen Labs Submits First US ANDA For Sitagliptin Tablets In 3 Strengths
Photo: Free Press Journal · view original

Mumbai: Morepen Laboratories Ltd announced on 28 September 2026, the submission of its first Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) for Sitagliptin Tablets USP. The submission includes 25 mg, 50 mg, and 100 mg strengths of the tablets. Expanding CDM...

Sources and story details